Selected research
Market Structure
Global Oxiracetam API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Oxiracetam API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Oxiracetam API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Oxiracetam API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Oxiracetam API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Oxiracetam API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Oxiracetam API include Shaanxi Laon Biotech Co., Ltd., Shandong Green Chemical, Kono Chem Co.,Ltd., Chongqing Fuan Pharmaceutical, Union Pharma Co., Ltd., Shanghai CRM New Material Technology and Chemi SpA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Oxiracetam API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Oxiracetam API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Oxiracetam API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oxiracetam API market size, projected growth trends, production technologies, key applications, and end-use industries.
Oxiracetam API Segment by Company
Shaanxi Laon Biotech Co., Ltd.
Shandong Green Chemical
Kono Chem Co.,Ltd.
Chongqing Fuan Pharmaceutical
Union Pharma Co., Ltd.
Shanghai CRM New Material Technology
Chemi SpA
Oxiracetam API Segment by Type
Purity: 99%
Purity: >99%
Oxiracetam API Segment by Application
Oxiracetam Injection
Oxiracetam Tablets
Oxiracetam Capsules
Oxiracetam API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxiracetam API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxiracetam API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxiracetam API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Oxiracetam API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oxiracetam API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oxiracetam API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Oxiracetam API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Purity: 99%
- Purity: >99%
Applications
- Oxiracetam Injection
- Oxiracetam Tablets
- Oxiracetam Capsules
Companies covered
- Shaanxi Laon Biotech Co., Ltd.
- Shandong Green Chemical
- Kono Chem Co.,Ltd.
- Chongqing Fuan Pharmaceutical
- Union Pharma Co., Ltd.
- Shanghai CRM New Material Technology
- Chemi SpA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Oxiracetam API Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Oxiracetam API Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Oxiracetam API Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Oxiracetam API Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Oxiracetam API Market Dynamics
- 2.1 Oxiracetam API Industry Trends
- 2.2 Oxiracetam API Industry Drivers
- 2.3 Oxiracetam API Industry Opportunities and Challenges
- 2.4 Oxiracetam API Industry Restraints
3 Oxiracetam API Market by Manufacturers
- 3.1 Global Oxiracetam API Revenue by Manufacturers (2021-2026)
- 3.2 Global Oxiracetam API Sales by Manufacturers (2021-2026)
- 3.3 Global Oxiracetam API Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Oxiracetam API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Oxiracetam API Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Oxiracetam API Manufacturers, Product Type & Application
- 3.7 Global Oxiracetam API Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Oxiracetam API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Oxiracetam API Players Market Share by Revenue in 2025
- 3.8.3 2025 Oxiracetam API Tier 1, Tier 2, and Tier 3
4 Oxiracetam API Market by Type
- 4.1 Oxiracetam API Type Introduction
- 4.1.1 Purity: 99%
- 4.1.2 Purity: >99%
- 4.2 Global Oxiracetam API Sales by Type
- 4.2.1 Global Oxiracetam API Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Oxiracetam API Sales by Type (2021-2032)
- 4.2.3 Global Oxiracetam API Sales Market Share by Type (2021-2032)
- 4.3 Global Oxiracetam API Revenue by Type
- 4.3.1 Global Oxiracetam API Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Oxiracetam API Revenue by Type (2021-2032)
- 4.3.3 Global Oxiracetam API Revenue Market Share by Type (2021-2032)
5 Oxiracetam API Market by Application
- 5.1 Oxiracetam API Application Introduction
- 5.1.1 Oxiracetam Injection
- 5.1.2 Oxiracetam Tablets
- 5.1.3 Oxiracetam Capsules
- 5.2 Global Oxiracetam API Sales by Application
- 5.2.1 Global Oxiracetam API Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Oxiracetam API Sales by Application (2021-2032)
- 5.2.3 Global Oxiracetam API Sales Market Share by Application (2021-2032)
- 5.3 Global Oxiracetam API Revenue by Application
- 5.3.1 Global Oxiracetam API Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Oxiracetam API Revenue by Application (2021-2032)
- 5.3.3 Global Oxiracetam API Revenue Market Share by Application (2021-2032)
6 Global Oxiracetam API Sales by Region
- 6.1 Global Oxiracetam API Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Oxiracetam API Sales by Region (2021-2032)
- 6.2.1 Global Oxiracetam API Sales by Region (2021-2026)
- 6.2.2 Global Oxiracetam API Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Oxiracetam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Oxiracetam API Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Oxiracetam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Oxiracetam API Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Oxiracetam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Oxiracetam API Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Oxiracetam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Oxiracetam API Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Oxiracetam API Revenue by Region
- 7.1 Global Oxiracetam API Revenue by Region
- 7.1.1 Global Oxiracetam API Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Oxiracetam API Revenue by Region (2021-2026)
- 7.1.3 Global Oxiracetam API Revenue by Region (2027-2032)
- 7.1.4 Global Oxiracetam API Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Oxiracetam API Revenue (2021-2032)
- 7.2.2 North America Oxiracetam API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Oxiracetam API Revenue (2021-2032)
- 7.3.2 Europe Oxiracetam API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Oxiracetam API Revenue (2021-2032)
- 7.4.2 Asia-Pacific Oxiracetam API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Oxiracetam API Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Oxiracetam API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Shaanxi Laon Biotech Co., Ltd.
- 8.1.1 Shaanxi Laon Biotech Co., Ltd. Company Information
- 8.1.2 Shaanxi Laon Biotech Co., Ltd. Business Overview
- 8.1.3 Shaanxi Laon Biotech Co., Ltd. Oxiracetam API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Shaanxi Laon Biotech Co., Ltd. Oxiracetam API Product Portfolio
- 8.1.5 Shaanxi Laon Biotech Co., Ltd. Recent Developments
- 8.2 Shandong Green Chemical
- 8.2.1 Shandong Green Chemical Company Information
- 8.2.2 Shandong Green Chemical Business Overview
- 8.2.3 Shandong Green Chemical Oxiracetam API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Shandong Green Chemical Oxiracetam API Product Portfolio
- 8.2.5 Shandong Green Chemical Recent Developments
- 8.3 Kono Chem Co.,Ltd.
- 8.3.1 Kono Chem Co.,Ltd. Company Information
- 8.3.2 Kono Chem Co.,Ltd. Business Overview
- 8.3.3 Kono Chem Co.,Ltd. Oxiracetam API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Kono Chem Co.,Ltd. Oxiracetam API Product Portfolio
- 8.3.5 Kono Chem Co.,Ltd. Recent Developments
- 8.4 Chongqing Fuan Pharmaceutical
- 8.4.1 Chongqing Fuan Pharmaceutical Company Information
- 8.4.2 Chongqing Fuan Pharmaceutical Business Overview
- 8.4.3 Chongqing Fuan Pharmaceutical Oxiracetam API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Chongqing Fuan Pharmaceutical Oxiracetam API Product Portfolio
- 8.4.5 Chongqing Fuan Pharmaceutical Recent Developments
- 8.5 Union Pharma Co., Ltd.
- 8.5.1 Union Pharma Co., Ltd. Company Information
- 8.5.2 Union Pharma Co., Ltd. Business Overview
- 8.5.3 Union Pharma Co., Ltd. Oxiracetam API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Union Pharma Co., Ltd. Oxiracetam API Product Portfolio
- 8.5.5 Union Pharma Co., Ltd. Recent Developments
- 8.6 Shanghai CRM New Material Technology
- 8.6.1 Shanghai CRM New Material Technology Company Information
- 8.6.2 Shanghai CRM New Material Technology Business Overview
- 8.6.3 Shanghai CRM New Material Technology Oxiracetam API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Shanghai CRM New Material Technology Oxiracetam API Product Portfolio
- 8.6.5 Shanghai CRM New Material Technology Recent Developments
- 8.7 Chemi SpA
- 8.7.1 Chemi SpA Company Information
- 8.7.2 Chemi SpA Business Overview
- 8.7.3 Chemi SpA Oxiracetam API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Chemi SpA Oxiracetam API Product Portfolio
- 8.7.5 Chemi SpA Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Oxiracetam API Value Chain Analysis
- 9.1.1 Oxiracetam API Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Oxiracetam API Production Mode & Process
- 9.2 Oxiracetam API Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Oxiracetam API Distributors
- 9.2.3 Oxiracetam API Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst